Laddar...

Immunomodulatory Drugs Regulate HMGB1 Release from Activated Human Monocytes

Several HMGB1-specific antagonists have provided beneficial results in multiple models of inflammatory disease–preclinical trials including arthritis. Since no HMGB1-specific targeted therapy has yet reached the clinic, we have performed in vitro studies to investigate whether any of a selection of...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Schierbeck, Hanna, Wähämaa, Heidi, Andersson, Ulf, Harris, Helena Erlandsson
Materialtyp: Artigo
Språk:Inglês
Publicerad: ScholarOne 2010
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2935946/
https://ncbi.nlm.nih.gov/pubmed/20386869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2010.00031
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!